首页> 外文期刊>British journal of ophthalmology >Increased conjunctival expression of protease activated receptor 2 (PAR-2) in seasonal allergic conjunctivitis: a role for abnormal conjunctival epithelial permeability in disease pathogenesis?
【24h】

Increased conjunctival expression of protease activated receptor 2 (PAR-2) in seasonal allergic conjunctivitis: a role for abnormal conjunctival epithelial permeability in disease pathogenesis?

机译:季节性变应性结膜炎中蛋白酶激活受体2(PAR-2)的结膜表达增加:在疾病发病过程中结膜上皮通透性异常的作用?

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: Aeroallergen exposure to the conjunctival epithelium in seasonal allergic conjunctivitis (SAC) may induce a cellular stress response that disrupts the barrier properties of the conjunctival epithelium, resulting in allergic disease. Whether such changes occur in SAC is unknown. Epithelial permeability is known to be increased when protease activated receptor 2 (PAR-2) is activated. We evaluated the expression of PAR-2 in patients with SAC-in-season (SACS) and compared it with control non-atopic subjects or those with out-of-season allergic conjunctivitis (OSAC). METHODS: Six SACS, eight normal and four OSAC specimens were examined immunohistochemically for PAR-2 and quantified in a masked fashion for the percentage of epithelia stained for each marker using Image-J software. Conjunctival epithelial heights were measured in all groups to confirm the presence of allergic eye disease. RESULTS: Mean percentage staining of PAR-2 was significantly greater in SACS that in normal specimens (73.4 +/- 15.4% vs 32.8 +/- 30.0%, p=0.038) or in OSAC (73.4 +/- 15.4% vs 1.4 +/- 2.2%, p=0.01). Mean conjunctival epithelial height was significantly raised in SACS (63.8 +/- 9.0 mum) versus controls (44.7 +/- 11.2 mum) (p=0.003, unpaired t test). CONCLUSIONS: Conjunctival epithelial PAR-2 is significantly upregulated in SAC. This supports the view that disruption of the barrier properties of the conjunctival epithelium is an important event in SAC pathogenesis.
机译:目的:在季节性变应性结膜炎(SAC)中,空气过敏原接触结膜上皮可能会诱导细胞应激反应,破坏结膜上皮的屏障特性,从而导致变应性疾病。 SAC中是否发生此类更改尚不清楚。已知当蛋白酶激活的受体2(PAR-2)被激活时,上皮通透性会增加。我们评估了SAC季节患者(SACS)患者中PAR-2的表达,并将其与非过敏性对照人群或季节性变应性结膜炎(OSAC)患者进行了比较。方法:采用免疫组化法对6份SACS,8份正常和4份OSAC标本进行了PAR-2免疫组化检查,并使用Image-J软件以掩盖方式对每种标记物染色的上皮百分比进行了定量。测量所有组的结膜上皮高度,以确认是否存在过敏性眼病。结果:在SACS中,PAR-2的平均染色百分比显着高于正常标本(73.4 +/- 15.4%vs 32.8 +/- 30.0%,p = 0.038)或OSAC(73.4 +/- 15.4%vs 1.4 + /-2.2%,p = 0.01)。 SACS(63.8 +/- 9.0毫米)与对照组(44.7 +/- 11.2毫米)相比,平均结膜上皮高度显着升高(p = 0.003,未配对t检验)。结论:结膜上皮PAR-2在SAC中明显上调。这支持以下观点:结膜上皮的屏障特性的破坏是SAC发病机理中的重要事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号